12:00 AM
Apr 11, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Eniluracil: Phase II started

Adherex began the open-label, international Phase II (AHX-03-202) trial in about 140 patients to compare 40 mg oral eniluracil weekly for the first 3 weeks of a...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >